Rx-360, an international pharmaceutical and biotech industry supply chain consortium, has set up a program of joint audits. The goal of this project is to expand audit coverage and reduce duplicated audit efforts. SAFC recently took part in a pilot audit program.
Here we discuss how the joint audits work and what the advantages are for both pharmaceutical companies and their suppliers.
Rx-360 was set up in 2009 in response to a number of supply chain failures that led to patient deaths and to address concerns about how these failures might be prevented. Its aim is to create and monitor a global quality system that sets industry expectations and regulations to assure patient safety by enhancing product quality and authenticity throughout the supply chain.